Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Veracyte Inc shares valued at $38,326 were purchased by ANN MCGUIRE on Mar 04 ’25. At $33.56 per share, ANN MCGUIRE acquired 1,142 shares.
Also, MARC STAPLEY purchased 52,697 shares, netting a total of over 1,768,511 in proceeds.
Before that, PHILLIP FEBBO had added 8,037 shares to its account. In a trade valued at $269,722, the Officer bought Veracyte Inc shares for $33.56 each.
As published in a research note from Goldman on December 05, 2024, Veracyte Inc [VCYT] has been rated down from a Buy to a Neutral and the price target has been revised to $37 from $38. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November. As of October 16, 2024, UBS has initiated its “Buy” rating for VCYT. Earlier on October 10, 2024, Guggenheim initiated its rating. Their recommendation was “a Buy” for VCYT stock.
Analyzing VCYT Stock Performance
During the last five days, there has been a drop of approximately -7.23%. Over the course of the year, Veracyte Inc shares have dropped approximately -16.77%. Shares of the company reached a 52-week high of $47.32 on 01/30/25 and a 52-week low of $32.27 on 03/04/25. A 50-day SMA is recorded $40.88, while a 200-day SMA reached $32.97.
Support And Resistance Levels for Veracyte Inc (VCYT)
According to the 24-hour chart, there is a support level at 32.28, which, if violated, would cause prices to drop to 31.60. In the upper region, resistance lies at 34.00. The next price resistance is at 35.04. RSI (Relative Strength Index) is 33.81 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.67, which suggests the price will decrease in the coming days. Percent R is at 93.15%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
